[1] HAUGEN B R, ALEXANDER E K, BIBLE K C, et al.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1): 1-133. [2] LEE S L.Complications of Radioactive Iodine Treatment of Thyroid Carcinoma[J]. Journal of the National Comprehensive Cancer Network, 2010, 8(11): 1277-1287. [3] 林岩松, 李娇. 2015年美国甲状腺学会《成人甲状腺结节与分化型甲状腺癌诊治指南》解读:分化型甲状腺癌~(131)I治疗新进展[J]. 中国癌症杂志, 2016, 26(1): 1-12. [4] HOLLINGSWORTH B, SENTER L, ZHANG X, et al.Risk Factors of 131I-Induced Salivary Gland Damage in Thyroid Cancer Patients[J]. J Clin Endocrinol Metab, 2016, 101(11): 4085-4093. [5] 代思明, 孙佳莹, 张志毅. 干燥综合征合并自身免疫性甲状腺疾病[J]. 中国实用内科杂志, 2017, 37(6): 488-491. [6] 宋芹, 毛玉景, 郭向华, 等. 结缔组织病与甲状腺疾病的相关性[J]. 中华临床免疫和变态反应杂志, 2014, 8(1): 52-56. [7] WARTOFSKY L, VAN NOSTRAND D.Thyroid cancer: A comprehensive guide to clinical management[M]. 3rd ed. New york: Springer, 2016. [8] 向苗, 张俊. 综合护理对分化型甲状腺癌患者术后碘-131治疗的不良反应影响[J]. 中西医结合护理(中英文), 2021, 7(1): 122-124. [9] 王秀萍, 韦智晓, 姚菊丽, 等. 基于MEWS评分的SBAR沟通对甲状腺癌碘-131治疗患者的影响[J]. 齐鲁护理杂志, 2023, 29(24): 56-59. [10] 李小艳, 郭颖. 优质护理在分化型甲状腺癌患者术后碘-131治疗的不良反应处理中的应用[J]. 中国误诊学杂志, 2020, 15(4): 172-174. |